Ionis Pharmaceuticals Inc (IONS)

41.56
+0.31(+0.75%)
After Hours
41.56
0.00(0.00%)
- Real-time Data
  • Volume:
    465,328
  • Day's Range:
    40.52 - 41.90
  • 52 wk Range:
    25.04 - 48.82

IONS Overview

Prev. Close
41.25
Day's Range
40.52-41.9
Revenue
568.57M
Open
41.08
52 wk Range
25.04-48.82
EPS
0.052
Volume
465,328
Market Cap
5.9B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,038,194
P/E Ratio
836.77
Beta
0.548
1-Year Change
39.65%
Shares Outstanding
141,941,338
Next Earnings Date
Feb 22, 2023
What is your sentiment on Ionis Pharma?
or
Market is currently closed. Voting is open during market hours.

Ionis Pharmaceuticals Inc News

Ionis Pharmaceuticals Inc Analysis

Ionis Pharmaceuticals Inc Company Profile

Ionis Pharmaceuticals Inc Company Profile

Employees
660

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.

Read More

Analyst Price Target

Average52.95 (+27.41% Upside)
High92
Low26
Price41.56
No. of Analysts21
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellSellStrong SellNeutral
Technical IndicatorsStrong SellSellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellBuy